Document is current

Article History

Received: 18 July 2025

Accepted: 11 September 2025

First Online: 8 October 2025

Declarations

:

: Amanda Harrington is an employee of Pharming Healthcare, Inc. François Laliberté, Guillaume Germain, and Malena Mahendran are employees of Groupe d’analyse, which received research funding from Pharming Healthcare, Inc., to conduct this study. At the time of the study, Ana Urosevic was an employee of Groupe d’analyse, SRI, Montréal, Québec, Canada. She is currently affiliated with Royal Bank of Canada, Toronto, Canada. Nicholas L. Rider received research funding from Pharming Healthcare, Inc., to conduct this study and serves on an advisory board and steering committee for Pharming Healthcare, Inc. No author received payment for the writing of this manuscript.

: Analyses in this study included only deidentified insurance claims data; therefore, institutional review board approval and patient consent for study participation or publication of study findings were not required. Permission was obtained from Symphony Health Solutions Corporation, allowing use of data from its database for this study. This study was performed in accordance with the Helsinki Declaration of 1964 and its later amendments and in compliance with the US patient confidentiality requirement of the Health Insurance Portability and Accountability Act.